Navigation Links
Breaking news: Study revives Olympic prospects for amputee sprinter
Date:5/16/2008

A world-renowned team of experts in biomechanics and physiology from six universities, led by Professor Hugh Herr of the Massachusetts Institute of Technologys Media Lab, refute scientific claims that the prostheses worn by Oscar Pistorius, a 21-year-old South African bilateral amputee track athlete, provide him with an unfair advantage in the 400-meter race. Their conclusions were based on data collected at the Rice University Locomotion Laboratory, under the direction of Professor Peter Weyand. Pistorius hopes to run in the 400-meter race at the Beijing Olympics this summer.

Based on the teams findings, the Court of Arbitration for Sports (CAS) in Lausanne, Switzerland, has ruled that Pistorius is eligible to participate in International Association of Athletics Federations (IAAF) sanctioned competitions. If he qualifies for the 2008 Beijing games, Pistorius would be the first disabled athlete ever to run against able-bodied athletes in an Olympic event.

The teams findings were presented to the CAS April 29-30 by Herr and Professor Rodger Kram of the University of Colorado at Boulder, and provided the foundation for Pistorius appeal to overturn the IAAF decision that previously banned him from running against able-bodied athletes in races that are governed by IAAF rules. The team's findings were presented at the CAS, where Pistorius was represented by the international law firm of Dewey & LeBoeuf on a pro-bono basis.

In addition to Herr, Weyand and Kram, the panel of experts included Professor Matthew Bundle from the University of Wyoming, an expert in the energetics and mechanics of sprinting performance; Craig McGowan, from the University of Texas at Austin, a leading authority on muscle, tendon and joint mechanics; Alena Grabowski, from the Massachusetts Institute of Technology, an expert in human locomotor energetics and biomechanics; and Jean-Benot Morin from the University of Saint-Etienne, an expert in the mechanics of
'/>"/>

Contact: David Ruth
druth@rice.edu
713-348-6327
Rice University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Shell-breaking crabs lived 20 million years earlier than thought
2. BGSU undergraduates to pilot groundbreaking genome project
3. Scientists discover record-breaking hydrogen storage materials for use in fuel cells
4. Speed plays crucial role in breaking proteins H-bonds
5. Groundbreaking Canada-US study proves link between emissions and mercury pollution in fish
6. Groundbreaking Canada-US study proves link between emissions and mercury pollution in fish
7. UC health news: molecular pathway may predict chemotherapy effectiveness
8. New study casts further doubt on risk of death from higher salt intake
9. Crystal (eye) ball: Study says visual system equipped with future seeing powers
10. Warming climate is changing life on global scale, says new study
11. NASA study links Earth impacts to human-caused climate change
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, ... the start of a new Phase III double blind, ... its novel formulation, CM-AT, on all children ages 3-8 ... its FDA Phase III double blinded clinical trial for ... low levels of the digestive enzyme chymotrypsin. This new ...
(Date:5/5/2015)... , May 5, 2015, NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market, reminds investors and ... Technology Officer, is presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, ... 2015. The three-day conference is organized into ... speaking in is themed Global Fraud: Where is the ...
(Date:4/20/2015)... Calif. , April 20, 2015 Huntington ... Gabriel Valley to implant a new miniaturized, wireless monitoring ... System is the first and only FDA-approved heart failure ... hospital admissions when used by physicians to manage heart ... sensor that is implanted in the pulmonary artery (PA) ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
... therapy often harms healthy tissue as it tries to kill ... Department of Biomedical Engineering is developing a new way to ... surrounding tissue. His innovative method, soon to be ... kill the tumor cells but leaves surrounding healthy tissue intact. ...
... a leading cause of mortality worldwide, accounting for more than ... expected to exceed 12 million. The ESMO Congress provides a ... the treatment of cancer Congress Program Highlights ... potentially practice changing, Promising new drugs to treat ovarian, skin, ...
... Under the microscope, the bacteria start dividing normally, two ... then individual cells begin "popping," like circus balloons being struck ... bioengineers who captured it on video, turns out to be ... considered by scientists creating living, synthetic circuits out of bacteria. ...
Cached Biology News:A 'magnetic' solution to identify and kill tumors 235th ESMO Congress media alert 235th ESMO Congress media alert 3Popping cells surprise living circuits creators 2Popping cells surprise living circuits creators 3
(Date:5/27/2015)... THOUSAND OAKS, Calif. , May 27, 2015 /PRNewswire/ ... company, has been awarded a U.S. patent for a ... gene in areas such as research, product development and ... useful in regulating key biosynthetic processes that are the ... to offer other seed companies a commercial license to ...
(Date:5/26/2015)... OTTAWA, Canada, and BELLINGHAM, Washington, USA (PRWEB) May 26, ... has signed a formal partnership with the ... Ottawa Centre for Extreme and Quantum Photonics. The center ... in the field of photonics, and will be only ... Arthurs, CEO of SPIE, the international society for ...
(Date:5/26/2015)... and HILDEN, Germany , May ... (NASDAQ: QGEN ; Frankfurt Prime Standard: QIA) ... Clinical Insight ® (QCI™) bioinformatics content and ... and report on genomic variants identified in next-generation ... the bioinformatics platform are in oncology, for somatic ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Global ... have announced plans for the company’s first cellular and ... followed by a full day, hands-on stem cell training ... J. Victor Garcia Gimenez, M.D., President of Therapeutic Confrontations ... medical community’s increasing interest in regenerative medicine and recent ...
Breaking Biology Technology:Ceres Awarded Patent for Innovation in Soybean 2Ceres Awarded Patent for Innovation in Soybean 3Third Max Planck Centre in North America Inaugurated at University of Ottawa 2Third Max Planck Centre in North America Inaugurated at University of Ottawa 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 2QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 4QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 5Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 2Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 3
... Adult Cough Products Using ... Technologies, CHESTER, N.J. and SALT LAKE CITY, Sept. ... and Lipocine Inc., a,privately- held, leading drug delivery company ... drug delivery and,therapeutics needs, today announced that they have ...
... Company Enters Into License, Commercialization and Supply Agreement, Company to Host Conference ... ... 2007, LEXINGTON, Mass., Sept. 19 ... AGN ), through its acquisition of Esprit Pharma, has obtained the,United States ...
... Kleiner Perkins ... Strong Endorsement of Technology Pioneer at Forefront of Developing No- ... Compromise Biofuels, ... hydrocarbon biofuels, today,announced that it closed the first tranche of its $70 million ...
Cached Biology Technology:Adams Respiratory Therapeutics and Lipocine Enter into License and Collaboration Agreement 2Adams Respiratory Therapeutics and Lipocine Enter into License and Collaboration Agreement 3Indevus Announces Allergan as New Partner for SANCTURA Brand 2Indevus Announces Allergan as New Partner for SANCTURA Brand 3Indevus Announces Allergan as New Partner for SANCTURA Brand 4Indevus Announces Allergan as New Partner for SANCTURA Brand 5Indevus Announces Allergan as New Partner for SANCTURA Brand 6Amyris Biotechnologies Announces $70 Million Series B Round 2
Recognizes a full-length CLC-2 voltage-gated Cl- protein and not with other known proteins tested so far....
... 2 - BSA and Azide free ... applications). Antigen: ... corresponding to C terminal amino acids ... Entrez GeneID: 2064 ...
Potassium Channel kv3.2...
200 μg per ml DNA in 10 SSPE, 2 Denhardt's...
Biology Products: